Lytus Technologies Holdings PTV. Ltd.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Dharmesh Pandya
- Full Time Employees
- 3
- Sector
- Technology
- Industry
- Software - Application
- Address
- 601 Everest Grande, A Wing Mumbai India 400093
- IPO Date
- Jun 15, 2022
- CIK
- 0001816319
- Website
- lytus.in
- Similar Companies
- Business
- Lytus Technologies Holdings PTV. Ltd. (LYT) develops and provides technology platforms and services focused on digital content distribution, telemedicine, and smart mobility solutions. The company offers Lytus TV, a streaming service delivering over 400 live TV channels and 100,000+ hours of video-on-demand content across genres including movies, sports, and news; Lytus Health, a telemedicine platform providing virtual consultations, diagnostics, and healthcare management tools; and Lytus Mobility, an app-based ride-hailing and fleet management service. These offerings cater to consumers and enterprises in the media, healthcare, and transportation sectors, with operations spanning India, the United States, and select international markets. Founded in 2018 and headquartered in Mumbai, India, the company continues to expand its digital ecosystem without notable subsidiaries or parent affiliations. In recent developments, Lytus has pursued strategic growth through enhanced platform integrations and market penetration efforts, though no major acquisitions, funding rounds, or rebrands have been publicly announced in the last 1-2 years.
PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
PureTech's Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
PureTech Presents New Data from Phase 2b Open-Label Extension Study of Deupirfenidone (LYT-100), Further Supporting Strong and Durable Efficacy and Potential to Serve as New Standard of Care in IPF
Lytus Technologies announces 24% Revenue Growth for H1 FY2025
Lytus Technologies Expands HealthTech Initiatives and Strengthens Growth Trajectory
Lytus Technologies Expands Its Footprint into Healthcare with Cutting-Edge Patient-Centric HealthTech Platform
PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
Why Is Lytus Technologies (LYT) Stock Up 109% Today?
Lytus Technologies enters the audio entertainment sector with the launch of Radio Room, India's first regional Audio OTT platform
Join Lytus Technologies' Exclusive Live Investor Webinar and Q&A Session on March 27
Lytus Technologies and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
5 Investors Betting Big on Lytus Technologies (LYT) Stock
Why Is Lytus Technologies (LYT) Stock Up 223% Today?
Lytus Technologies Enters $326 Billion Data Center Market with Launch of Cutting-Edge Lytus Cloud Infrastructure Services
Lytus Technologies Holdings PTV. Ltd. announces 1 for 60 Reverse Stock Split
Why Is Lytus Technologies (LYT) Stock Up 26% Today?
Why Is Lytus Technologies (LYT) Stock Up 125% Today?
Top 4 Tech And Telecom Stocks That May Rocket Higher This Quarter - Cuentas (NASDAQ:CUEN), Grom Social Enterprises (NASDAQ:GROM)
LYTUS TECHNOLOGIES LAUNCHES LYTUS STUDIOS